Current Drug Safety

0.8(top 50%)

impact factor

856(top 20%)

papers

9.9K(top 20%)

citations

40(top 20%)

h-index

0.9(top 50%)

impact factor

987

all documents

10.5K

doc citations

67(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent	Current Drug Safety	2011	422
2	Risks of Self-Medication Practices	Current Drug Safety	2010	288
3	Adverse Effects of Statins - Mechanisms and Consequences	Current Drug Safety	2009	179
4	QT Alterations in Psychopharmacology: Proven Candidates and Suspects	Current Drug Safety	2010	154
5	Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis	Current Drug Safety	2008	150
6	Desmopressin 30 Years in Clinical Use: A Safety Review	Current Drug Safety	2007	144
7	Antimalarial Drugs in Pregnancy: A Review	Current Drug Safety	2006	136
8	Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects	Current Drug Safety	2018	114
9	Lead Encephalopathy Due to Traditional Medicines	Current Drug Safety	2008	102
10	Risks Associated with SGLT2 Inhibitors: An Overview	Current Drug Safety	2018	97
11	Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies	Current Drug Safety	2013	95
12	Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?	Current Drug Safety	2009	92
13	Hypnotics and Driving Safety: Meta-Analyses of Randomized Controlled Trials Applying the on-the-Road Driving Test	Current Drug Safety	2006	82
14	Adverse Drug Reactions in Hospitals: A Narrative Review	Current Drug Safety	2007	82
15	Domperidone and Long QT Syndrome	Current Drug Safety	2010	78
16	Antineoplastic Chemotherapy Induced QTc Prolongation	Current Drug Safety	2010	73
17	Ketamine Induces Toxicity in Human Neurons Differentiated from Embryonic Stem Cells via Mitochondrial Apoptosis Pathway	Current Drug Safety	2012	73
18	Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management	Current Drug Safety	2016	70
19	Biodegradable Polymer-Metal Complexes for Gene and Drug Delivery	Current Drug Safety	2009	66
20	Mechanisms of Drug Induced QT Interval Prolongation	Current Drug Safety	2010	64
21	Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines	Current Drug Safety	2007	63
22	Zolpidem and Traffic Safety - The Importance of Treatment Compliance	Current Drug Safety	2007	63
23	Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study	Current Drug Safety	2018	62
24	Self-Medication with Antibiotics in Europe: A Case for Action	Current Drug Safety	2010	60
25	Hypertension, Antihypertensive Therapy and Renal-Cell Cancer: A Meta-Analysis	Current Drug Safety	2007	58
26	Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications	Current Drug Safety	2009	58
27	Drug-Induced Phototoxicity; An Early In Vitro Identification of Phototoxic Potential of New Drug Entities in Drug Discovery and Development	Current Drug Safety	2009	57
28	Update on the Adverse Effects of Clozapine: Focus on Myocarditis	Current Drug Safety	2012	56
29	Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature	Current Drug Safety	2018	55
30	Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends	Current Drug Safety	2007	54
31	Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children	Current Drug Safety	2008	54
32	CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis	Current Drug Safety	2013	52
33	Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin	Current Drug Safety	2007	51
34	Improving Safety of Gene Therapy	Current Drug Safety	2008	49
35	Hepatotoxicity Induced by Methimazole in a Previously Health Patient	Current Drug Safety	2009	47
36	Technology Utilization to Prevent Medication Errors	Current Drug Safety	2010	47
37	Safety and Efficacy of Melatonin in Pediatric Migraine Prophylaxis	Current Drug Safety	2015	47
38	Side Effects of Clozapine and Some Other Psychoactive Drugs	Current Drug Safety	2008	46
39	Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles	Current Drug Safety	2014	46
40	Liver Injury Associated with Antidepressants	Current Drug Safety	2013	45
41	Impulsive and Compulsive Behaviors During Dopamine Replacement Treatment in Parkinson’s Disease and Other Disorders	Current Drug Safety	2012	43
42	The Use of Metronidazole During Pregnancy: A Review of Evidence	Current Drug Safety	2015	41
43	Supervision in Primary Health Care - Can it be Carried Out Effectively in Developing Countries?	Current Drug Safety	2007	40
44	Vaping Versus Smoking: A Quest for Efficacy and Safety of E-cigarette	Current Drug Safety	2018	40
45	Drug-Induced Hair Disorders	Current Drug Safety	2006	39
46	Clozapine Safety, 40 Years Later	Current Drug Safety	2014	39
47	QT Interval Prolongation: Preclinical and Clinical Testing Arrhythmogenesis in Drugs and Regulatory Implications	Current Drug Safety	2010	38
48	The Frequency of Thrombotic Events Among Adults Given Antifibrinolytic Drugs for Spontaneous Bleeding: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials	Current Drug Safety	2012	38
49	Protective Effect of Edaravone on Cyclophosphamide Induced Oxidative Stress and Neurotoxicity in Rats	Current Drug Safety	2019	38
50	Treatment of Psoriasis: A Comprehensive Review of Entire Therapies	Current Drug Safety	2020	38

Scientometrics

Overviews

Citing Bodies

Current Drug Safety

Top Articles